Exclusive worldwide license agreement signed with the University of California at San Diego for two new, novel oxime drug technologies. June 18, 2014 • admin • General News, Pharmaceuticals Read More »
Countervail Corporation presents significant results of i.m. dosed AverTox (galantamine) for improved survival from exposure to lethal levels of soman at the CounterACT Symposium held in Denver Colorado. June 7, 2014 • admin • Funding, General News Read More »
US CIP Patent awarded for use of galantamine as Method of Treating Organophosphorus Poisoning. April 3, 2014 • admin • General News Read More »
Countervail relocates and expands offices into new facilities at the Portal Building in Charlotte, NC. February 11, 2014 • admin • General News Read More »
Countervail Corporation Receives Additional $5.4 Million from BARDA For Continued Development of Medical Countermeasure to Nerve Agents October 25, 2013 • admin • Funding, General News, Pharmaceuticals Read More »
Countervail holds initial pre-IND meeting with Neurology Division of the FDA for guidance on development of a neuroprotectant against sub-lethal nerve agent exposure. October 5, 2012 • admin • General News Read More »
US Parent Patent awarded for use of galantamine as Method of Treating Organophosphorus Poisoning. February 2, 2011 • admin • Agriculture, General News, Military Read More »
New Charlotte, NC office opened at the Ben Craig Center Business Incubator September 2, 2010 • admin • General News Read More »
Countervail wins business plan competition at 8th annual Five Ventures conference. Out of 130 competing companies, Countervail wins the Biotechnology – Pharmaceutical division for best business plan presentation. April 30, 2009 • admin • General News, Uncategorized Read More »
Countervail’s principal investigator presents at 2009 NINDS CounterACT meeting in Washington, DC. Dr. Edson Albuquerque presents additional data on galantamine’s effectiveness in preserving survival and prevention of neural cell damage from nerve agent exposure. April 14, 2009 • admin • General News Read More »